Cargando…
Efficacy and Tolerability of a Combined Moxifloxacin/Dexamethasone Formulation for Topical Prophylaxis in Phacoemulsification: An Open-Label Single-Arm Clinical Trial
Background. The use of a fixed-combination antibiotic corticosteroid for infection prophylaxis in Asian patients undergoing phacoemulsification has not been reported. Methods. A 15-day, open-label, single-arm trial of 64 patients for phacoemulsification with intraocular lens (IOL) implantation is de...
Autores principales: | Espiritu, Cesar Ramon G., Sy, Mary Ellen A., Tayengco, Tommee Lynne G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136157/ https://www.ncbi.nlm.nih.gov/pubmed/21772987 http://dx.doi.org/10.1155/2011/769571 |
Ejemplares similares
-
Safety of intracameral application of moxifloxacin and dexamethasone (Vigadexa®) after phacoemulsification surgery
por: Galvis, Virgilio, et al.
Publicado: (2023) -
Efficacy and tolerability of a fixed-dose moxifloxacin – dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial
por: Campos, Mauro, et al.
Publicado: (2008) -
Bilateral Acute Iris Transillumination Syndrome after Topical Moxifloxacin/Dexamethasone Initially Misdiagnosed as Uveitis: Case Report
por: da Costa, Daniella Socci, et al.
Publicado: (2023) -
Cohort Study of Intracameral Moxifloxacin in Postoperative Endophthalmitis Prophylaxis
por: Galvis, Virgilio, et al.
Publicado: (2014) -
Topical anesthesia in phacoemulsification
por: Waheeb, Saad
Publicado: (2010)